Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |